Session » Vasculitis – ANCA-Associated (2048–2052)
- 11:00AM-11:50AM
-
Abstract Number: 2050
Autoantibodies Targeting Complement Receptors C3aR and C5aR1 Are Decreased in ANCA-associated Vasculitis and Correlate with a Higher Relapse Rate
- 11:00AM-11:50AM
-
Abstract Number: 2048
Comparison of Two Rituximab Regimens for Induction of Remission in Antineutrophil Cytoplasm Antibody-associated Vasculitis: Systematic Review and Meta-analysis
- 11:00AM-11:50AM
-
Abstract Number: 2052
Extended Follow-Up of Patients Recruited to a Randomized, Controlled Trial of Rituximab versus Azathioprine After Induction of Remission with Rituximab for Patients with ANCA-Associated Vasculitis and Relapsing Disease
- 11:00AM-11:50AM
-
Abstract Number: 2051
Localized versus Systemic Granulomatosis with Polyangiitis: Data from the French Vasculitis Study Group Database
- 11:00AM-11:50AM
-
Abstract Number: 2049
Nasal Bacteria Associated with Disease Activity and ANCA Levels in Granulomatosis with Polyangiitis